Abstracts tagged "Early Rheumatoid Arthritis and anti-CCP antibodies"

Abstract Number: 1438 • 2014 ACR/ARHP Annual Meeting
Association Between Chronic Inflammatory Conditions and Anti Cyclic Citrullinated Peptide Antibodies in Patients with Early Rheumatoid Arthritis
Lucila Marino¹, Marta Mamani², Antonio Catalán Pellet², Fernando Dal Pra³, Gustavo Citera⁴, Margarita Landi³, O Cerda⁵, Alejandro Martinez⁶, Rafael Chaparro del Moral⁷, Oscar L. Rillo⁶, Francisco Colombres⁸, Alberto Berman^8,9, Horacio Berman⁸, Josefina Marcos¹⁰, Mercedes García¹⁰, A Salas¹⁰, Francisco Caeiro¹¹, AC Alvarez¹², Maria Haye Salinas¹¹, N Benzaquen¹², Enrique Soriano¹³, Javier Rosa¹⁴, Emanuel Bertiller¹⁴, Federico Ceccato¹⁵, Sergio O. Paira¹⁵, Gabriela Salvatierra¹⁶, C Ledesma¹⁶, Ana Quinteros¹⁷, M Leal^17,18, Maria Elena Crespo¹⁹, V Juarez¹⁹, Edson Veloso²⁰, Mónica P. Sacnun²¹, R. Quintana²¹, Marcelo Abdala²² and Anastasia Secco², ¹Rheumathology, Hospital Bernardino Rivadavia, Buenos Aires, Argentina, ²Rheumatology, Hospital Bernardino Rivadavia, Buenos Aires, Argentina, ³Instituto de Rehabilitacion Psicofisica, Buenos Aires, Argentina, ⁴Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, ⁵Rheumatology, Instituto de Rehabilitacion Psicofisica, Buenos Aires, Argentina, ⁶Rheumatology Unit, Hospital General de Agudos Dr. E. Tornú, Buenos Aires, Argentina, ⁷Rheumatology Section, Hospital General de Agudos Dr. E. Tornú, Buenos Aires, Argentina, ⁸Centro Medico Privado de Reumatologia, Tucumán, Argentina, ⁹Centro Medico Privado de Reumatologia, Tucuman, Argentina, ¹⁰HIGA San Martín, La Plata, Argentina, ¹¹Reumatología, Hospital Privado de Córdoba, Córdoba, Argentina, ¹²Hospital Privado Centro Médico de, Córdoba, Argentina, ¹³Rheumatology Unit, Internal Medical Services, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, ¹⁴Hospital Italiano, Buenos Aires, Argentina, ¹⁵Hospital Jose Maria Cullen, Santa Fe, Argentina, ¹⁶Instituto Provincial De Rehabilitación Integral, Stgo. del Estero, Argentina, ¹⁷Centro Integral de Reumatología, Tucumán, Argentina, ¹⁸Centro Integral De Reumatologia, Tucumán, Argentina, ¹⁹Hospital Señor Del Milagro, Salta, Argentina, ²⁰Sanatorio y Universidad Adventista Del Plata, Entre Rios, Argentina, ²¹Hospital Provincial, Rosario, Argentina, ²²Hospital Provincial del Centenario, Santa Fe, Argentina
Background/Purpose : Increased citrullination process and anti–CCP production are not restricted to rheumatoid arthritis (RA). Other inflammatory processes could develop citrullinated proteins which may contribute…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].